Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sorkin

Showing results (171-180 of 1,188) with videos related to

Pageof 119
Sort By:
Biochemistry|April 22, 1997
Spectroscopic measurement of a long-predicted active site pK in iron-superoxide dismutase from Escherichia coliD L Sorkin, A F Miller
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1986
The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysisB Piraino, J Bernardini, M Sorkin
Langmuir : the ACS Journal of Surfaces and Colloids|July 2, 2017
Effect of Cholesterol on the Stability and Lubrication Efficiency of Phosphatidylcholine Surface LayersRaya Sorkin, Nir Kampf, Jacob Klein
Drugs|September 1, 1992
Enoxaparin. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disordersM M Buckley, E M Sorkin
Drugs & Aging|January 1, 1991
Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disordersM W Vernon, E M Sorkin
Journal of the Peripheral Nervous System : JPNS|July 25, 2000
Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake ratL S Sorkin, C M Doom
Plos One|May 19, 2012
Shoc2 is targeted to late endosomes and required for Erk1/2 activation in EGF-stimulated cellsEmilia Galperin, Lina Abdelmoti, Alexander Sorkin
Drugs|March 1, 1988
Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacyP A Todd, E M Sorkin
Drugs|May 1, 1993
Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsyD H Peters, E M Sorkin
Advances in Nutrition (Bethesda, Md.)|December 4, 2014
Caffeine-containing energy drinks: beginning to address the gaps in what we knowBarbara C Sorkin, Paul M Coates
Pageof 119

Showing results (171-180 of 1,188) with videos related to

Sort By:
Pageof 119
Biochemistry|April 22, 1997
Spectroscopic measurement of a long-predicted active site pK in iron-superoxide dismutase from Escherichia coliD L Sorkin, A F Miller
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1986
The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysisB Piraino, J Bernardini, M Sorkin
Langmuir : the ACS Journal of Surfaces and Colloids|July 2, 2017
Effect of Cholesterol on the Stability and Lubrication Efficiency of Phosphatidylcholine Surface LayersRaya Sorkin, Nir Kampf, Jacob Klein
Drugs|September 1, 1992
Enoxaparin. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disordersM M Buckley, E M Sorkin
Drugs & Aging|January 1, 1991
Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disordersM W Vernon, E M Sorkin
Journal of the Peripheral Nervous System : JPNS|July 25, 2000
Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake ratL S Sorkin, C M Doom
Plos One|May 19, 2012
Shoc2 is targeted to late endosomes and required for Erk1/2 activation in EGF-stimulated cellsEmilia Galperin, Lina Abdelmoti, Alexander Sorkin
Drugs|March 1, 1988
Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacyP A Todd, E M Sorkin
Drugs|May 1, 1993
Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsyD H Peters, E M Sorkin
Advances in Nutrition (Bethesda, Md.)|December 4, 2014
Caffeine-containing energy drinks: beginning to address the gaps in what we knowBarbara C Sorkin, Paul M Coates
Pageof 119